Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer H Kohler

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Chemical Communications (Cambridge, England)|October 19, 2013
A photoactivatable drug-caged fluorophore conjugate allows direct quantification of intracellular drug transportSarit S Agasti, Ashley M Laughney, Rainer H Kohler, et al.
Theranostics|April 25, 2017
Design and Development of Fluorescent Vemurafenib Analogs for <i>In Vivo</i> ImagingHannes Mikula, Shawn Stapleton, Rainer H Kohler, et al.
Bioconjugate Chemistry|May 9, 2014
In vivo imaging of multidrug resistance using a third generation MDR1 inhibitorMelissa M Sprachman, Ashley M Laughney, Rainer H Kohler, et al.
Scientific Reports|May 19, 2015
Single cell resolution in vivo imaging of DNA damage following PARP inhibitionKatherine S Yang, Rainer H Kohler, Matthieu Landon, et al.
Scientific Reports|April 25, 2014
Single cell imaging of Bruton's tyrosine kinase using an irreversible inhibitorAnna Turetsky, Eunha Kim, Rainer H Kohler, et al.
Advanced Therapeutics|May 17, 2021
SMALL MOLECULE IMAGING AGENT FOR MUTANT KRAS G12CPeter D Koch, Jeremy Quintana, Maaz Ahmed, et al.
Journal of Biomedical Optics|May 6, 2006
Detection of macrophage activity in atherosclerosis in vivo using multichannel, high-resolution laser scanning fluorescence microscopyAshvin N Pande, Rainer H Kohler, Elena Aikawa, et al.
ACS Chemical Biology|December 7, 2019
Imaging of Tie2 with a Fluorescently Labeled Small Molecule Affinity LigandPeter David Koch, Maaz S Ahmed, Rainer H Kohler, et al.
Chemmedchem|February 8, 2014
Platinum compounds for high-resolution in vivo cancer imagingMiles A Miller, Bjorn Askevold, Katherine S Yang, et al.
Molecular Cancer Therapeutics|February 21, 2014
Effect of small-molecule modification on single-cell pharmacokinetics of PARP inhibitorsGreg M Thurber, Thomas Reiner, Katherine S Yang, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Chemical Communications (Cambridge, England)|October 19, 2013
A photoactivatable drug-caged fluorophore conjugate allows direct quantification of intracellular drug transportSarit S Agasti, Ashley M Laughney, Rainer H Kohler, et al.
Theranostics|April 25, 2017
Design and Development of Fluorescent Vemurafenib Analogs for <i>In Vivo</i> ImagingHannes Mikula, Shawn Stapleton, Rainer H Kohler, et al.
Bioconjugate Chemistry|May 9, 2014
In vivo imaging of multidrug resistance using a third generation MDR1 inhibitorMelissa M Sprachman, Ashley M Laughney, Rainer H Kohler, et al.
Scientific Reports|May 19, 2015
Single cell resolution in vivo imaging of DNA damage following PARP inhibitionKatherine S Yang, Rainer H Kohler, Matthieu Landon, et al.
Scientific Reports|April 25, 2014
Single cell imaging of Bruton's tyrosine kinase using an irreversible inhibitorAnna Turetsky, Eunha Kim, Rainer H Kohler, et al.
Advanced Therapeutics|May 17, 2021
SMALL MOLECULE IMAGING AGENT FOR MUTANT KRAS G12CPeter D Koch, Jeremy Quintana, Maaz Ahmed, et al.
Journal of Biomedical Optics|May 6, 2006
Detection of macrophage activity in atherosclerosis in vivo using multichannel, high-resolution laser scanning fluorescence microscopyAshvin N Pande, Rainer H Kohler, Elena Aikawa, et al.
ACS Chemical Biology|December 7, 2019
Imaging of Tie2 with a Fluorescently Labeled Small Molecule Affinity LigandPeter David Koch, Maaz S Ahmed, Rainer H Kohler, et al.
Chemmedchem|February 8, 2014
Platinum compounds for high-resolution in vivo cancer imagingMiles A Miller, Bjorn Askevold, Katherine S Yang, et al.
Molecular Cancer Therapeutics|February 21, 2014
Effect of small-molecule modification on single-cell pharmacokinetics of PARP inhibitorsGreg M Thurber, Thomas Reiner, Katherine S Yang, et al.
Pageof 7